Microbicide Trials Network

MTN-020 - ASPIRE

MTN-020 - ASPIRE
 
ASPIRE - A Study to Prevent Infection with a Ring for Extended Use – is a Phase III safety and effectiveness trial of a vaginal ring containing the antiretroviral dapivirine that opened in August 2012 and enrolled 2,629 women at several sites in Africa. The dapivirine vaginal ring was developed by the International Partnership for Microbicides, which is conducting another Phase III trial, The Ring Study, in parallel with ASPIRE.
 
See
29-June-2015
 
26-June-2014
  
24-July-2012
  
7-October-2013  
  
June 2015
  
26-June-2015
 
See Also